6 April 2022 – On the 14th March 2022, Nordhealth AS (the "Company") announced the acquisition of Vetera and a 19.26% stake in Pet Leo and today announces an increase in the share capital by issuing consideration shares to partially settle the transaction.
Further reference is made to the stock exchange announcement on 14 March 2022 by Nordhealth AS regarding the Company’s acquisition of Vetera and a 19.26% stake in Pet Leo. The signed acquisition is subject to customary closing conditions with expected closing during Q2 2022.
The share capital increase pertaining to the NOK 5,441,779.86 reinvestment by key employees and owners (the “Reinvestment”) was resolved by the Board of Directors of the Company (the "Board") today, on 6 April 2022 pursuant to an authorization granted by the Company's general meeting held 17 February, 2022. The Reinvestment is considered to be in the best interest of the Company and its shareholders, taking into account the expected values added to the group through completion of the acquisition and the incentives alignment for management.
The share capital will be increased by NOK 191,747, divided into 191,747 Class A shares, each with nominal value of NOK 1.00. Following registration of the share capital increase pertaining to the Reinvestment, the Company will have a share capital of NOK 80,191,746, divided into 45,191,747 Class A shares and 34,999,999 Class B shares, each with nominal value of NOK 1.00. The subscription price is NOK 28.38 per share of which NOK 1.00 is share capital and NOK 27.38 is share premium/other paid-in equity. The total subscription amount is NOK 5,441,779.86 of which NOK 191,747 is share capital and NOK 5,250,032.86 is share premium/other paid-in equity.
For further information, please contact:
Charles Macbain, CEO
charles.macbain@nordhealth.com
+44 75 39 03 2200
Mari Orttenvuori, CFO
mari.orttenvuori@nordhealth.com
+358 46 8765 233
About Nordhealth
Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine digital healthcare. The Company’s products empower healthcare professionals to improve patient care, increase efficiency and expand their business. Since 2005, the Company has acquired and built cloud-based software for veterinary and therapeutic professionals and their patients, and now serves more than 30,000 professionals across 7,000 clinics and hospitals located in over 25 countries.
Headquartered in Espoo, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 300 employees working either remotely or from offices (collaboration hubs), serving a global customer base. Visit the company’s website at nordhealth.com.